Last Updated on June 13, 2024 by The Health Master
Marketing
The Indian government is taking a stricter stance on ethical pharmaceutical marketing practices.
On May 28th, 2024, the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers issued a circular mandating all pharmaceutical companies to submit a self-declaration of compliance with the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024.
This deadline for submission is set for June 30th, 2024.
What is the UCPMP and Why is Self-Declaration Important?
The UCPMP serves as a critical guideline for ethical marketing practices within the Indian pharmaceutical industry.
It ensures transparency and fair competition while protecting healthcare professionals and patients from misleading or unethical marketing tactics.
This self-declaration process aims to:
Increase Transparency:
By requiring companies to formally acknowledge their adherence to the UCPMP, the government promotes greater transparency in marketing practices.
Enhance Accountability:
Self-declaration holds companies accountable for upholding ethical marketing standards, deterring potential misconduct.
Strengthen Enforcement:
The self-declaration serves as a valuable tool for regulatory bodies to identify and address any non-compliance issues.
What Does the Self-Declaration Entail?
The circular provides a standardized format for the self-declaration document.
This document includes:
- A clear statement by the company’s executive head acknowledging their commitment to adhering to the UCPMP 2024 provisions.
- A pledge to offer full cooperation with authorities during the enforcement process of the code.
- Company information, including the name and headquarters location.
- Signature and official seal of the company.
What This Means for Indian Pharmaceutical Companies
All pharmaceutical companies operating in India must prioritize familiarizing themselves with the UCPMP 2024 guidelines.
By June 30th, 2024, they must complete and submit the self-declaration form to the designated authorities.
This initiative emphasizes the government’s dedication to ensuring responsible and ethical marketing practices within the pharmaceutical sector.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
UCPMP: New Uniform Code for Pharmaceutical Marketing Practices: An Overview
Ensuring Ethical Pharmaceutical Marketing Practices: A Comprehensive Analysis
Govt and Pharma Industry to discuss ethical Marketing Practices
Govt constitutes committee to regulate Pharma Marketing Practices
Nutraceuticals in Drug Units: Panel to examine the issue
CDSCO underscores stringent compliance to Revised Schedule M
USFDA issues OAI status to Eugia Pharma of Aurobindo
Can Your Air Handling Meet the new Schedule M? Find Out Here
New R&D Policy Ushers in Era of Collaboration and Efficiency
Govt Job: For Pharmacists under Public Service Commission
FSSAI warns against sale of human milk and its products in India
USFDA approval granted for the generic Lanreotide injection
USFDA issues warning letter to Laurus Labs for Andhra Facility
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
